相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys
Gunasingh J. Masilamoni et al.
BRAIN (2011)
The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease
Alessandro Tozzi et al.
JOURNAL OF NEUROSCIENCE (2011)
Modulation of the striato-pallidal pathway by adenosine A2a receptors depends on dopaminergic striatal input
Enrique Querejeta et al.
BRAIN RESEARCH (2010)
Gliotransmission: Exocytotic release from astrocytes
Vladimir Parpura et al.
BRAIN RESEARCH REVIEWS (2010)
Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders
Robert A. Hodgson et al.
EXPERIMENTAL NEUROLOGY (2010)
Reduction of L-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
Tom H. Johnston et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Adenosine A2Areceptors and their role in drug addiction
Robyn M. Brown et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Caffeine and CSC, adenosine A(2A) antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells
Helio Vitoriano Nobre et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys
Nicolas Morin et al.
NEUROPHARMACOLOGY (2010)
Istradefylline as monotherapy for Parkinson disease: Results of the 6002-US-051 trial
H. H. Fernandez et al.
PARKINSONISM & RELATED DISORDERS (2010)
The thalamostriatal systems: Anatomical and functional organization in normal and parkinsonian states
Yoland Smith et al.
BRAIN RESEARCH BULLETIN (2009)
Novel investigational adenosine A2A receptor antagonists for Parkinson's disease
Annalisa Pinna
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells
Nuria Cabello et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Adenosine A2A receptor mediates microglial process retraction
Anna G. Orr et al.
NATURE NEUROSCIENCE (2009)
Dopamine D2 and Adenosine A2A Receptors Regulate NMDA-Mediated Excitation in Accumbens Neurons Through A2A-D2 Receptor Heteromerization
Karima Azdad et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Key Modulatory Role of Presynaptic Adenosine A(2A) Receptors in Cortical Neurotransmission to the Striatal Direct Pathway
Cesar Quiroz et al.
THESCIENTIFICWORLDJOURNAL (2009)
Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces Off' time in Parkinson's disease:: A double-blind, randomized, multicenter clinical trial (6002-US-005)
Peter A. LeWitt et al.
ANNALS OF NEUROLOGY (2008)
Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders
Rodrigo A. Cunha et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Adenosine A2A receptor dynamics studied with the novel fluorescent agonist Alexa488-APEC
Frank Brand et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
G protein-coupled receptors in and on the cell nucleus: A new signaling paradigm?
Benoit Boivin et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2008)
Study of Istradefylline in Patients with Parkinson's Disease on Levodopa with Motor Fluctuations
Robert A. Hauser et al.
MOVEMENT DISORDERS (2008)
A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease
M. Stacy et al.
NEUROLOGY (2008)
Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats
Cameron L. Adams et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Adenosine A2A receptors and basal ganglia physiology
S. N. Schiffmann et al.
PROGRESS IN NEUROBIOLOGY (2007)
Role of adenosine A2A receptors in parkinsonian motor impairment and L-DOPA-induced motor complications
Micaela Morelli et al.
PROGRESS IN NEUROBIOLOGY (2007)
Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry -: Implications for drug addiction, sleep and pain
S. Ferre et al.
PROGRESS IN NEUROBIOLOGY (2007)
Modulation of glial cell functions by adenosine receptors
Elisabetta Dare et al.
PHYSIOLOGY & BEHAVIOR (2007)
Evaluation of distribution of adenosine A2A receptors in normal human brain measured with [11C]TMSX PET
Masahiro Mishina et al.
SYNAPSE (2007)
Effect of the adenosine A2a receptor antagonist 3,7-dimethyl-propargylxanthine on anxiety-like and depression-like behavior and alcohol consumption in wistar rats
Annika Thorsell et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2007)
Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease
Annalisa Pinna et al.
SYNAPSE (2007)
An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats
K. Ossowska et al.
AMINO ACIDS (2007)
Comparative analysis of the subcellular and subsynaptic localization of mGluR1a and mGluR5 metabotropic glutamate receptors in the shell and core of the nucleus accumbens in rat and monkey
Darlene A. Mitrano et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
Adenosine released by astrocytes contributes to hypoxia-induced modulation of synaptic transmission
Eduardo D. Martin et al.
GLIA (2007)
Glutamate and GABA receptors and transporters in the basal ganglia: What does their subsynaptic localization reveal about their function?
A. Galvan et al.
NEUROSCIENCE (2006)
Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats
Dinesh V. Raju et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
Functional coupling of the Gαolf variant XLGαolf with the human adenosine A2A receptor
Vipa Ravyn et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2006)
The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2a receptor
T Milojevic et al.
MOLECULAR PHARMACOLOGY (2006)
Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers
F Ciruela et al.
JOURNAL OF NEUROSCIENCE (2006)
Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice
A Kachroo et al.
JOURNAL OF NEUROSCIENCE (2005)
Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus:: a possible key mechanism in the modulation of N-methyl-D-aspartate effects
MT Tebano et al.
JOURNAL OF NEUROCHEMISTRY (2005)
MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats
K Ossowska et al.
NEUROPHARMACOLOGY (2005)
KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse
M Pierri et al.
NEUROPHARMACOLOGY (2005)
Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP
JA Aguirre et al.
BRAIN RESEARCH (2005)
Co-localization and functional interaction between adenosine A2A and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum
RJ Rodrigues et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Neuroprotection induced by the adenosine A(2A) antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways
J Bove et al.
EXPERIMENTAL BRAIN RESEARCH (2005)
Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
G Battaglia et al.
JOURNAL OF NEUROSCIENCE (2004)
Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization.: Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors
F Ciruela et al.
ANALYTICAL CHEMISTRY (2004)
The thalamostriatal system: a highly specific network of the basal ganglia circuitry
Y Smith et al.
TRENDS IN NEUROSCIENCES (2004)
Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum
MR Domenici et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing parkinsonian deficits in rats
R Coccurello et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Age-related changes in the expression of axonal and glial group I metabotropic glutamate receptor in the rat substantia nigra pars reticulata
GW Hubert et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Subcellular and subsynaptic localization of group I metabotropic glutamate receptors in the monkey subthalamic nucleus
M Kuwajima et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Striatal plasticity at the network level.: Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease
S Tanganelli et al.
PARKINSONISM & RELATED DISORDERS (2004)
Adenosine A2A receptor-induced inhibition of NMDA and GABAA receptor-mediated synaptic currents in a subpopulation of rat striatal neurons
K Wirkner et al.
NEUROPHARMACOLOGY (2004)
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias
F Calon et al.
BRAIN (2004)
Adenosine A2A-dopamine D2 receptor-receptor heteromerization -: Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer
M Canals et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease
F Bibbiani et al.
EXPERIMENTAL NEUROLOGY (2003)
Adenosine A2A receptor antagonist treatment of Parkinson's disease
W Bara-Jimenez et al.
NEUROLOGY (2003)
Randomized trial of the adenosine A2A receptor antagonist istradefylline in advanced PD
RA Hauser et al.
NEUROLOGY (2003)
Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes
R Brambilla et al.
GLIA (2003)
Activation of metabotropic glutamate receptor mGlu5 on nuclear membranes mediates intranuclear Ca2+ changes in heterologous cell types and neurons
KL O'Malley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling
A Nishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Adenosine A2A receptors inhibit the N-methyl-D-aspartate component of excitatory synaptic currents in rat striatal neurons
Z Gerevich et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors:: Implications for striatal neuronal function
S Ferré et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A new neuromodulatory pathway with a glial contribution mediated via A2a adenosine receptors
T Nishizaki et al.
GLIA (2002)
Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors
J Hillion et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Anoxia redistributes adenosine A2A receptors in PC12 cells and increases receptor-mediated formation of cAMP
G Arslan et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2002)
The role of striatal metabotropic glutamate receptors in Parkinson's disease
K Ossowska et al.
AMINO ACIDS (2002)
Adenosine in the central nervous system: release mechanisms and extracellular concentrations
S Latini et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Adenosine/dopamine interaction:: implications for the treatment of Parkinson's disease
S Ferré et al.
PARKINSONISM & RELATED DISORDERS (2001)
Adenosine A2A receptor enhances GABAA-mediated IPSCs in the rat globus pallidus
T Shindou et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells
BB Fredholm et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors
RA Cunha
NEUROCHEMISTRY INTERNATIONAL (2001)
ATP as a presynaptic modulator
RA Cunha et al.
LIFE SCIENCES (2000)
Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum
I Strömberg et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Evidence for adenosine/dopamine receptor interactions:: Indications for heteromerization
R Franco et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Inhibition by adenosine A2A receptors of NMDA but not AMPA currents in rat neostriatal neurons
K Wirkner et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Combined use of the adenosine A2A antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys
T Kanda et al.
EXPERIMENTAL NEUROLOGY (2000)
Adenosine A(2A) receptor gene expression in the normal striatum and after 6-OH-dopamine lesion
A Kaelin-Lang et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: A microdialysis study
M Ochi et al.
NEUROSCIENCE (2000)
分享论文
